INOX India Ltd (INOXINDIA) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- INOX India delivered a strong Q4 and FY25, achieving robust top-line and bottom-line growth, driven by solid execution and consistent order inflow across all business segments.
- The company met its full-year guidance and strengthened its leadership in next-generation energy and cryogenic solutions.
- Key achievements include securing the first order from Australia for IMO containers, marking entry into a new competitive space and validating the long-term strategy.
- INOX India played a pivotal role in developing India's first indigenous MRI machine by manufacturing the 4K helium cryostat, reducing medical device import dependency.
- The Savli plant is fully commissioned and exceeded INR 200 crore turnover in its first year of operation.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.